D-10TM HEMOGLOBIN A1C PROGRAM - COFEPRIS Registration 898R2019 SSA
Access comprehensive regulatory information for D-10TM HEMOGLOBIN A1C PROGRAM (D-10TM HEMOGLOBIN A1C PROGRAM) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 898R2019 SSA and manufactured by BIO-RAD, S.A.. The device was registered on May 02, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL D-10TM HEMOGLOBIN A1C PROGRAM HA SIDO DISEÑADO PARA LA DETERMINACIÓN CUANTITATIVA DE LOS NIVELES DE HEMOGLOBINA A1C (MMOL/MOL DE IFCC Y % DE NGSP) EN SANGRE HUMANA UTILIZANDO LA CROMATOGRAFÍA LÍQUIDA DE ALTA RESOLUCIÓN (HPLC) POR INTERCAMBIO IÓNICO EN
THE D-10TM HEMOGLOBIN A1C PROGRAM HAS BEEN DESIGNED FOR THE QUANTITATIVE DETERMINATION OF HEMOGLOBIN A1C LEVELS (IFCC MMOL/MOL AND NGSP% %) IN HUMAN BLOOD USING ION EXCHANGE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) IN